Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
New Jersey Gov. Chris Christie's secret gastric band surgery in February has stolen front-page headlines today. His weight is often the target of comedic fodder, but it was a legitimate concern surrounding his overall health.
This news has gotten the political media stirring that the governor is planning a White House run in 2016, but here at the Fool we're more concerned with investing than with politics. With more than 200,000 stomach-shrinking procedures performed per year, is there money to be made for investors?
In this video, Motley Fool health-care analyst David Williamson takes a closer look at the companies and highlights why this may be no slam-dunk for investors.
What could be a slam-dunk for investors is a stock working to eradicate the macro trend Warren Buffett called "the tapeworm that's eating at American competitiveness." Find out what Buffett was referring to in our free report: "What's Really Eating at America's Competitiveness." Just click here for free, immediate access.
Follow David on Twitter: @MotleyDavid.